Ron Kusters is a full professor at the University of Twente, Enschede and a specialist laboratory medicine, head of the laboratory for clinical chemistry and haematology at the Jeroen Bosch Hospital in Den Bosch.
He obtained his PhD in 1992 at the University of Utrecht and after a post-doc at the Vrije Universiteit Amsterdam, he started his internship in laboratory medicine at the Medisch Spectrum Twente in Enschede. As a board certified clinical biochemist, he joined the Jeroen Bosch Hospital, one of the larger teaching hospitals in the Netherlands in 1998. In 2000 he was appointed medical manager (head of laboratory). In 2005, he was recognized as supervisor to interns in laboratory medicine and up till 2021, he supervised 11 residents in laboratory medicine.
At the University of Twente he was appointed professor (part time) in 2011. His chair is at the department of health technology and services research, part of the Technical Medical Centre. His inaugural lecture (Dutch) may be found at https://goo.gl/mQLubr.
His research (https://goo.gl/BasxuM) focuses on clinical and economical effectiveness of laboratory diagnostics with particular interest in innovative biochemical markers and innovative diagnostic technologies, like point of care testing
Expertise
Medicine and Dentistry
- Patient
- Diagnosis
- Primary Health Care
- Laboratory
- Laboratory Test
- General Practitioner
- Inpatient
- General Medicine
Organisations
Ancillary activities
- Direct Diagnostics/Sanquinadvisory
- METC Brabantmember of METC Brabant
- Jeroen Bosch ZiekenhuisKlinisch Chemicus en medisch manager
Publications
2024
Optimising VTE exclusion in general practice: Using capillary quantitative point-of-care D-dimer testing across various contexts. University of Twente. Heerink, J. S.https://doi.org/10.3990/1.9789036560511Predicting hemoglobinopathies using ChatGPT, e59-e61. Kurstjens, S., Schipper, A., Krabbe, J. & Kusters, R.https://doi.org/10.1515/cclm-2023-0885
2023
Two point-of-care test-based approaches for the exclusion of deep vein thrombosis in general practice: a cost-effectiveness analysis, Article 42. Heerink, J. S., Nies, J., Koffijberg, H., Oudega, R., Kip, M. M. A. & Kusters, R.https://doi.org/10.1186/s12875-023-01992-zAre the latest point-of-care D-dimer devices ready for use in general practice?: A prospective clinical evaluation of five test systems with a capillary blood feature for suspected venous thromboembolism, 113-122. Heerink, J. S., Oudega, R., Gemen, E., Hopstaken, R., Koffijberg, H. & Kusters, R.https://doi.org/10.1016/j.thromres.2023.10.014Clinical decision rules in primary care: necessary investments for sustainable healthcare, Article e34. Heerink, J. S., Oudega, R., Hopstaken, R., Koffijberg, H. & Kusters, R.https://doi.org/10.1017/S146342362300021X
2022
The societal impact of implementing an at-home blood sampling device for chronic care patients: patient preferences and cost impact, Article 1529. Lingervelder, D., Kip, M. M. A., Wiese, E. D., Koffijberg, H., Ijzerman, M. J. & Kusters, R.https://doi.org/10.1186/s12913-022-08782-wAutomated prediction of low ferritin concentrations using a machine learning algorithm, 1921-1928. Kurstjens, S., De Bel, T., van der Horst, A., Kusters, R., Krabbe, J. & van Balveren, J.https://doi.org/10.1515/cclm-2021-1194How to Realize the Benefits of Point-of-Care Testing at the General Practice: A Comparison of Four High-Income Countries, 2248-2260. Lingervelder, D., Koffijberg, H., Emery, J. D., Fennessy, P., Price, C. P., van Marwijk, H., Eide, T. B., Sandberg, S., Cals, J. W. L., Derksen, J. T. M., Kusters, R. & IJzerman, M. J.https://doi.org/10.34172/ijhpm.2021.143Added Diagnostic Value of Biomarkers in Patients with Suspected Sepsis: A Prospective Cohort Study in Out-Of-Hours Primary Care, 1088-1097. Loots, F. J., Smits, M., Jenniskens, K., van Zanten, A. R. H., Kusters, R., Verheij, T. J. M. & Hopstaken, R. M.https://doi.org/10.1093/jalm/jfac031Clinical prediction models for mortality in patients with covid-19: external validation and individual participant data meta-analysis, Article e069881. De Jong, V. M. T., Rousset, R. Z., Antonio-Villa, N. E., Buenen, A. G., Van Calster, B., Bello-Chavolla, O. Y., Brunskill, N. J., Curcin, V., Damen, J. A. A., Fermín-Martínez, C. A., Fernández-Chirino, L., Ferrari, D., Free, R. C., Gupta, R. K., Haldar, P., Hedberg, P., Korang, S. K., Kurstjens, S., Kusters, R., … Debray, T. P. A.https://doi.org/10.1136/bmj-2021-069881New clinical prediction model for early recognition of sepsis in adult primary care patients: a prospective diagnostic cohort study of development and external validation, E437-E445. Loots, F., Smits, M., Hopstaken, R. M., Jenniskens, K., Schroeten, F. H., Bruel, A. v. d., van de Pol, A. C., Oosterheert, J. J., Bouma, H., Little, P., Moore, M., van Delft, S., Rijpsma, D., Holkenborg, J., van Bussel, B. C. T., Laven, R., Bergmans, D. C. J. J., Hoogerwerf, J. J., Latten, G. H. P., … Verheij, T. J. M.https://doi.org/10.3399/BJGP.2021.0520Drug laboratory test interactions in clinical practice: Improving laboratory test interpretation by creating awareness. University of Twente. van Balveren, J. A.https://doi.org/10.3990/1.9789464194883The adoption of point-of-care testing in primary care: Health economic evidence and organisational factors. University of Twente. Lingervelder, D.https://doi.org/10.3990/1.9789036553681Implementation of a care pathway for deep vein thrombosis: What's the benefit?, Article 100109. Heerink, J. S., Péquériaux, N., Oudega, R., de Jong, M., Koffijberg, H. & Kusters, R.https://doi.org/10.1016/j.tru.2022.100109Awareness of drug laboratory test interactions is important for prevention of unnecessary additional diagnostics: An example, 99-103. van Balveren, J. A., Erdem-Eraslan, L., Verboeket-van de Venne, W. P. H. G., Doggen, C. J. M., Hofland, J., Oosterhuis, W. P., de Rijke, Y. B., Hoedemakers, R. M. J. & Kusters, R.https://doi.org/10.1016/j.cca.2022.03.013Added value of drug-laboratory test interaction alerts in test result authorisation, E108-E111. van Balveren, J. A., Verboeket-van de Venne, W. P. H. G., Doggen, C. J. M., Erdem-Eraslan, L., de Graaf, A. J., Krabbe, J. G., Musson, R. E. A., Oosterhuis, W. P., De Rijke, Y. B., van der Sijs, H., Tintu, A. N., Verheul, R. J., Hoedemakers, R. M. J. & Kusters, R.https://doi.org/10.1515/cclm-2022-0077Performance of C-Reactive Protein, Procalcitonin, TAT Complex, and Factor VIII in Addition to D-Dimer in the Exclusion of Venous Thromboembolism in Primary Care Patients, 444-455. Heerink, J. S., Gemen, E., Oudega, R., Geersing, G. J., Hopstaken, R. & Kusters, R.https://doi.org/10.1093/jalm/jfab094
2021
Real-time monitoring of drug laboratory test interactions: A proof of concept, 235-242. van Balveren, J. A., Verboeket-van de Venne, W. P. H. G., Doggen, C. J. M., Erdem-Eraslan, L., De Graaf, A. J., Krabbe, J. G., Musson, R. E. A., Oosterhuis, W. P., De Rijke, Y. B., Van Der Sijs, H., Tintu, A. N., Verheul, R. J., Hoedemakers, R. M. J. & Kusters, R.https://doi.org/10.1515/cclm-2021-0790Performance of commercially-available cholesterol self-tests, 289-296. Kurstjens, S., Gemen, E., Walk, S., Njo, T., Krabbe, J., Gijzen, K., Elisen, M. G. L. M. & Kusters, R.https://doi.org/10.1177/0004563221992393Health Economic Evidence of Point-of-Care Testing: A Systematic Review, 157-173. Lingervelder, D., Koffijberg, H., Kusters, R. & IJzerman, M. J.https://doi.org/10.1007/s41669-020-00248-1Clinical usefulness of drug-laboratory test interaction alerts: A multicentre survey, 1239-1245. van Balveren, J. A., Verboeket-Van de Venne, W. P. H. G., Doggen, C. J. M., Cornelissen, A. S., Erdem-Eraslan, L., de Graaf, A. J., Krabbe, J. G., Musson, R. E. A., Oosterhuis, W. P., de Rijke, Y. B., van der Sijs, H., Tintu, A. N., Verheul, R. J., Hoedemakers, R. M. J. & Kusters, R.https://doi.org/10.1515/cclm-2020-1770
2020
Analytical performance and user-friendliness of five novel point-of-care D-dimer assays, 433-440. Heerink, J., Gemen, E., Oudega, R., Hopstaken, R., Geersing, G. J. & Kusters, R.https://doi.org/10.1080/00365513.2020.1768586Preventing overuse of laboratory diagnostics: a case study into diagnosing anaemia in Dutch general practice, Article 178. Kip, M. M. A., Oonk, M. L. J., Levin, M. D., Schop, A., Bindels, P. J. E., Kusters, R. & Koffijberg, H.https://doi.org/10.1186/s12911-020-01198-8Rapid identification of SARS-CoV-2-infected patients at the emergency department using routine testing, 1587-1593. Kurstjens, S., Van Der Horst, A., Herpers, R., Geerits, M. W. L., Kluiters-De Hingh, Y. C. M., Göttgens, E. L., Blaauw, M. J. T., Thelen, M. H. M., Elisen, M. G. L. M. & Kusters, R.https://doi.org/10.1515/cclm-2020-0593
2019
More information worse decisions?: Evaluating potential overuse of laboratory diagnostics in anaemia. Kip, M., Oonk, M. L. J., Levin, M. D. L., Kusters, G. C. M. & Koffijberg, E.
Research profiles
Courses academic year 2023/2024
Courses in the current academic year are added at the moment they are finalised in the Osiris system. Therefore it is possible that the list is not yet complete for the whole academic year.
Scan the QR code or